Jtr. Lawrence et Mj. Birnbaum, ADP-ribosylation factor 6 delineates separate pathways used by endothelin 1 and insulin for stimulating glucose uptake in 3T3-L1 adipocytes, MOL CELL B, 21(15), 2001, pp. 5276-5285
In 3T3-L1 adipocytes, both insulin and endothelin 1 stimulate glucose trans
port via translocation of the GLUT4 glucose carrier from an intracellular c
ompartment to the cell surface, Yet it remains uncertain as to whether both
hormones utilize identical pathways and to what extent each depends on the
heterotrimeric G protein G alphaq as an intermediary signaling molecule. I
n this study, we used a novel inducible system to rapidly and synchronously
activate expression of a dominant inhibitory form of ADP-ribosylation fact
or 6, ARF6 T27N, in 3T3-L1 adipocytes and assessed its effects on insulin-
and endothelin-stimulated hexose uptake. Expression of ARF6(T27N) in 3T3-L1
adipocytes was without effect on the ability of insulin to stimulate eithe
r 2-deoxyglucose uptake of the translocation of GLUT4 or GLUT1 to the plasm
a membrane. However, the same ARF6 inhibitory mutant blocked the stimulatio
n of hexose uptake and GLUT4 translocation in response to either endothelin
1 or an activated form of G alphaq, G alphaq(Q209L), These results suggest
that endothelin stimulates glucose transport through a pathway that is dis
tinct from that utilized by insulin but is likely to depend on both a heter
otrimeric G protein from the Gq family and the small G protein ARF6. These
data are consistent with the interpretation that endothelin and insulin sti
mulate functionally different pools of glucose transporters to be redistrib
uted to the plasma membrane.